AQC-Pattern Accordion-Collapse Accordion-Expand Agenda-Map CROs Consulting Download Email Fax Filter-Check Filter-Remove LinkedIn Map-Pin Member-Login Pharma-Biotech-Devices Phone Summit-Registration Survey-Research The-Avoca-Group-Consulting-And-Research-Services-Horizontal The-Avoca-Group-Diligent-Prequalification-Platform-Horizontal The-Avoca-Group-Quality-Consortium-Horizontal Training avoca-logo-coloravoca-logo-graycheckconsulting_logo2 diligent_logo2 dots dotted-01 dotted down-arrow GroupCreated with Sketch. minus plus quality_logo2 right-arrow twitter

Virtual DIA 2020 Global Annual Meeting


DIA 2020 is Now Virtual  |  June 14-18, 2020

DIA is pleased to announce that much of the invaluable content, communication, and community that defines the DIA 2020 Global Annual Meeting will still go on, in the digital realm! The lively panel presentations, insightful Q&A sessions, and deep community exchanges you’ve come to expect will be carried on, through DIA’s digital technology. Details on how we’ll be bringing you this new digital learning and networking adventure are forthcoming. In the meantime, please save the dates of June 14-18!


Join Avoca for the Following Session:

Thursday, June 18  •  9:30am – 10:30am

Qualification and Oversight in Decentralized Trials: Practical Considerations for Clinical Operations and Quality Oversight

Component Type: Forum

Level: Intermediate

In this interactive panel discussion, we will explore the critical role that providers, sponsors, and collaboratives play in driving greater adoption of decentralized clinical trials (DTs). Attendees are encouraged to engage in the discussion.

Learning Objectives: Define familiarity with the use of technologies and approaches enabling DTs; Identify challenges of vendor qualification for DTs versus traditional trials; Describe key risks when qualifying DT service providers; Characterize change management elements of success and how providers can support this effort; Describe role collaboratives and standards play in facilitating broader adoption of DTs.



Dennis Salotti, MBA, MS

Chief Operating Officer, The Avoca Group




Alison Holland

Head of Decentralized Trials and Remote Trials, Medable


Heather Zigmund, PharmD

Senior Director, Global Head of Study Management Early Stage Development BioPharmaceuticals R&D, AstraZeneca